Clinical efficacy of camrelizumab combined with lunvatinib or bevacizumab in the treatment of hepatocellular carcinoma

Lai Fengting; Liu Huaqiang; Cai Yongguang

doi:10.3969/j.issn.0253-9802.2023.06.012

Lai Fengting, Liu Huaqiang, Cai Yongguang

JOURNAL OF NEW MEDICINE ›› 2023, Vol. 54 ›› Issue (6) : 437-441.

PDF(953 KB)

JOURNAL OF NEW MEDICINE ›› 2023, Vol. 54 ›› Issue (6) : 437-441. DOI: 10.3969/j.issn.0253-9802.2023.06.012

Original Research

Clinical efficacy of camrelizumab combined with lunvatinib or bevacizumab in the treatment of hepatocellular carcinoma

{{article.zuoZhe_EN}}

Author information +

History +

HeighLight

Abstract

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 54(6): 437-441 https://doi.org/10.3969/j.issn.0253-9802.2023.06.012

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

Funding

RIGHTS & PERMISSIONS

PDF(953 KB)

Accesses

Citation

Detail

Sections

Recommended

Received	Published
2022-12-25	2023-06-15
Issue Date
2023-07-14

Please choose a citation manager

Content to export